Form 4 for MRNA Moderna
Accepted 2023-03-03 00:00:00 ET · period of report 2023-03-01 · accession 0001127602-23-008679 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-03-03 | 2023-03-01+ | MRNA | Bancel Stephane | CEO, Dir | M - OptEx | $0.99 | +80.0K | 5.45M | +1% | +$79.2K |
| DM | 2023-03-03 | 2023-03-01+ | MRNA | Bancel Stephane | CEO, Dir | S - Sale+OE | $136.34 | -80.0K | 5.41M | -1% | -$10.91M |
| DM | 2023-03-03 | 2023-03-01+ | MRNA | Bancel Stephane | CEO, Dir | M - OptEx | $0.00 | -80.0K | 1.35M | -6% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-01 | M | A | 40,000 | $0.99 | 5,451,946 | D | — | — | |
| 2 | Common | Common Stock | 2023-03-01 | S | D | 11,319 | $134.34 | 5,440,627 | D | — | — | (F4) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $133.79 to $134.79. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 3 | Common | Common Stock | 2023-03-01 | S | D | 21,938 | $135.26 | 5,418,689 | D | — | — | (F5) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $134.80 to $135.79. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 4 | Common | Common Stock | 2023-03-01 | S | D | 5,593 | $136.17 | 5,413,096 | D | — | — | (F6) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $135.81 to $136.80. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 5 | Common | Common Stock | 2023-03-01 | S | D | 1,150 | $137.03 | 5,411,946 | D | — | — | (F7) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $136.82 to $137.58. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 6 | Common | Common Stock | 2023-03-02 | M | A | 40,000 | $0.99 | 5,451,946 | D | — | — | |
| 7 | Common | Common Stock | 2023-03-02 | S | D | 8,700 | $136.44 | 5,443,246 | D | — | — | (F8) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $135.88 to $136.88. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 8 | Common | Common Stock | 2023-03-02 | S | D | 17,541 | $137.42 | 5,425,705 | D | — | — | (F9) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $136.89 to $137.89. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 9 | Common | Common Stock | 2023-03-02 | S | D | 13,659 | $138.27 | 5,412,046 | D | — | — | (F10) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $137.90 to $138.90. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 10 | Common | Common Stock | 2023-03-02 | S | D | 100 | $139.03 | 5,411,946 | D | — | — | |
| 11 | Derivative | Stock Option (Right to Buy) | 2023-03-02 | M | D | 40,000 | $0.00 | 1,307,155 | D | $0.99 · — to 2023-08-19 | 40,000 Common Stock | (F11) This option is fully vested and exercisable. |
| 12 | Derivative | Stock Option (Right to Buy) | 2023-03-01 | M | D | 40,000 | $0.00 | 1,347,155 | D | $0.99 · — to 2023-08-19 | 40,000 Common Stock | (F11) This option is fully vested and exercisable. |